15 mai 2015
Eleven Biotherapeutics Presents Clinical Data on EBI-005 for the Treatment of Dry Eye Disease and Allergic Conjunctivitis
/http%3A%2F%2Fstorage.canalblog.com%2F67%2F93%2F1309572%2F104146153_o.png)
Eleven Biotherapeutics Presents Clinical Data on EBI-005 for the Treatment of Dry Eye Disease and Allergic Conjunctivitis at ARVO 2015 Annual Meeting NASDAQ:EBIO - Finances Eleven Biotherapeutics, Inc. http://www.finances.com Eleven Biotherapeutics, Inc....
